Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Diamyd Medical AB Plans to Delist from NasdaqOMX and to List on Another Marketplace


Monday, 22 Apr 2013 03:57pm EDT 

Diamyd Medical AB announced that at a Board meeting on April 22, 2013 in the Company, it was decided that the Company should apply for delisting from NasdaqOMX. It was also decided that the Company should be listed on another equities marketplace. The date for the delisting from NasdaqOMX will be decided together with NasdaqOMX. The intention is that the Company should be listed on Aktietorget or another similar equities marketplace at the same time as the share is delisted from NasdaqOMX. 

Company Quote

15.1
-0.3 -1.95%
19 Dec 2014